IRIS - Res&Arch Institutional Research Information System - Research & Archive

CAROTTI, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.055
AS - Asia 3.309
EU - Europa 2.793
SA - Sud America 536
AF - Africa 93
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.794
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.959
SG - Singapore 1.639
IT - Italia 671
IE - Irlanda 501
CN - Cina 484
HK - Hong Kong 420
RU - Federazione Russa 414
BR - Brasile 412
VN - Vietnam 252
UA - Ucraina 235
DE - Germania 212
FR - Francia 195
FI - Finlandia 142
GB - Regno Unito 109
IN - India 98
KR - Corea 94
SE - Svezia 93
PL - Polonia 60
AR - Argentina 56
BD - Bangladesh 50
TR - Turchia 41
CA - Canada 39
MX - Messico 36
JP - Giappone 35
NL - Olanda 29
UZ - Uzbekistan 27
ZA - Sudafrica 27
ID - Indonesia 21
BE - Belgio 19
CH - Svizzera 19
IQ - Iraq 19
CZ - Repubblica Ceca 18
AT - Austria 17
CO - Colombia 15
EG - Egitto 15
SA - Arabia Saudita 15
EC - Ecuador 14
ES - Italia 14
JO - Giordania 14
PH - Filippine 14
MA - Marocco 11
AE - Emirati Arabi Uniti 10
CL - Cile 10
IL - Israele 10
PK - Pakistan 10
TN - Tunisia 10
VE - Venezuela 10
GR - Grecia 9
LT - Lituania 9
NP - Nepal 9
KZ - Kazakistan 8
MY - Malesia 8
PY - Paraguay 8
DZ - Algeria 7
PE - Perù 6
AZ - Azerbaigian 5
AM - Armenia 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
JM - Giamaica 4
LB - Libano 4
AL - Albania 3
AU - Australia 3
EU - Europa 3
MD - Moldavia 3
OM - Oman 3
BB - Barbados 2
BF - Burkina Faso 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
DK - Danimarca 2
GE - Georgia 2
HU - Ungheria 2
KE - Kenya 2
KG - Kirghizistan 2
LY - Libia 2
ME - Montenegro 2
NO - Norvegia 2
PR - Porto Rico 2
PT - Portogallo 2
RS - Serbia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
DJ - Gibuti 1
DM - Dominica 1
GH - Ghana 1
GT - Guatemala 1
GY - Guiana 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
Totale 10.774
Salva come PNG Salva come JPEG
Città #
Singapore 1.182
Dublin 501
Chandler 483
Hong Kong 414
San Jose 388
Perugia 284
Ashburn 277
San Mateo 222
Boardman 181
Santa Clara 180
Moscow 142
Lauterbourg 122
Beijing 119
Medford 116
Princeton 115
Altamura 109
Jacksonville 108
Wilmington 97
Munich 91
Seoul 90
Lawrence 88
Ann Arbor 81
Los Angeles 75
Ho Chi Minh City 69
New York 64
Andover 56
Redmond 56
Dong Ket 50
Hanoi 50
The Dalles 46
São Paulo 40
Des Moines 39
Piscataway 32
Helsinki 31
Kraków 31
Rome 31
Chennai 30
Tokyo 29
Saint Petersburg 28
Warsaw 27
Falls Church 26
Dallas 24
Orem 23
Turku 22
Brooklyn 19
Izmir 18
Chicago 17
San Paolo di Civitate 17
Tashkent 17
Brussels 16
Montreal 16
Phoenix 16
Houston 15
Johannesburg 15
Norwalk 15
Shanghai 15
Boston 14
London 14
Mcallen 14
Redwood City 14
Woodbridge 14
Rio de Janeiro 13
Denver 12
Haiphong 12
Manchester 12
Mexico City 12
New Delhi 12
Nuremberg 12
Spoleto 12
Amman 11
Cairo 11
Milan 11
Poplar 11
Stockholm 11
Amsterdam 10
Ankara 10
Atlanta 10
Baghdad 10
Bologna 10
Fremont 10
Hefei 10
Lappeenranta 10
Toronto 10
Brasília 9
Campinas 9
Frankfurt am Main 9
Guangzhou 9
Guarulhos 9
Macerata 9
Belo Horizonte 8
Columbus 8
Curitiba 8
Da Nang 8
Mumbai 8
San Francisco 8
Cape Town 7
Medellín 7
Porto Alegre 7
Basingstoke 6
Biên Hòa 6
Totale 6.912
Salva come PNG Salva come JPEG
Nome #
Computational studies in enantioselective liquid chromatography: Forty years of evolution in docking- and molecular dynamics-based simulations 161
Application of the “inverted chirality columns approach” for the monitoring of asymmetric synthesis protocols 146
Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls 131
Tracking Hidden Binding Pockets Along the Molecular Recognition Path of l-Trp to Indoleamine 2,3-Dioxygenase 1 129
Integrated Fragment-Based Approaches on the Route to Novel IDO1 Modulators 126
N-Decyl-S-trityl-(R)-cysteine, a new chiral selector for "green" ligand-exchange chromatography applications 126
New Insights from Crystallographic Data: Diversity of Structural Motifs and Molecular Recognition Properties between Groups of IDO1 Structures 122
Enantioselective HPLC analysis to assist the chemical exploration of chiral imidazolines 120
Asymmetric synthesis of the four diastereoisomers of a novel non-steroidal farnesoid X receptor (FXR) agonist: Role of the chirality on the biological activity 118
Binding properties of different categories of IDO1 inhibitors: A microscale thermophoresis study 118
a-Amino-b-carboxymuconate-e-semialdehyde Decarboxylase (ACMSD) Inhibitors as Novel Modulators of de Novo Nicotinamide Adenine Dinucleotide (NAD+) Biosynthesis 118
Discovery and Structure–Activity Relationships of Novel ssDAF-12 Receptor Modulators 115
One-pot, telescoped synthesis of N-aryl-5-aminopyrazoles from anilines in environmentally benign conditions 113
1μs Molecular Dynamics Simulations to study the poisoning effect of the PARP-1 full length enzyme 112
Cyclopropyl Dafachronic Acid Stereoisomers as Conformationally Constrained DAF-12 Ligands 112
An Integrated Approach to Ligand- and Structure-Based Drug Design: Development and Application to a Series of Serine Protease Inhibitors 111
Targeting the FXR nuclear receptor through a virtual screening approach 109
Ion pairing to enhance antibiotic drug efficacy. A new approach to fight problematic infections? 109
Beyond Bile Acids: Targeting Farnesoid X Receptor (FXR) with Natural and Synthetic Ligands 108
Optimized one-pot derivatization and enantioseparation of cysteine: Application to the study of a dietary supplement 107
Fragment-based Design of Zwitterionic, Strong Cation- and Weak Anion-Exchange Type Mixed-mode Liquid Chromatography Ligands and their Chromatographic Exploration 107
Improved chromatographic diastereoresolution of cyclopropyl dafachronic acid derivatives using chiral anion exchangers 106
Structural Insights into Monoamine Oxidase Inhibitory Potency and Selectivity of 7-Substituted Coumarins from Ligand- and Target-Based Approaches 105
Fragment based drug design and diversity-oriented synthesis of carboxylic acid isosteres 104
Mixed-mode chromatography characteristics of chiralpak ZWIX(+) and ZWIX(−) and elucidation of their chromatographic orthogonality for LC × LC application 103
Binding models of reversible inhibitors to type-B monoamine oxidase 102
Targeting Wnt-driven cancers: Discovery of novel tankyrase inhibitors 102
Chromatograpic resolution of phenylethanolic-azole racemic compounds highlighted stereoselective inhibition of heme oxygenase-1 by (R)-enantiomers 102
Binding modes identification through molecular dynamic simulations: a case study with carnosine enantiomers and the Teicoplanin A2-2-based chiral stationary phase 102
Exploiting Chemical Toolboxes for the Expedited Generation of Tetracyclic Quinolines as a Novel Class of PXR Agonists 101
Turning a Tumor Microenvironment Pitfall into Opportunity: Discovery of Benzamidoxime as PD-L1 Ligand with pH-Dependent Potency 100
Chiral mobile phase in ligand-exchange chromatography of amino acids: Exploring the copper(II) salt anion effect with a computational approach 99
Successful rate gain by combination of multiple techniques 99
Elucidation of the chromatographic enantiomer elution order through computational studies 99
Hydrophilic interaction liquid chromatography of aminoglycoside antibiotics with a diol-type stationary phase 99
Estimating the hydrophobicity extent of molecular fragments using reversed‐phase liquid chromatography 98
Sequence variants in kynurenine aminotransferase II (KAT II) orthologs determine different potencies of the inhibitor S-ESBA 98
Investigating the allosteric reverse signalling of PARP inhibitors with microsecond molecular dynamic simulations and fluorescence anisotropy. 97
The Janus-faced nature of IDO1 in infectious diseases: Challenges and therapeutic opportunities 97
Integrating experimental and computational techniques to study chromatographic enantioresolutions of chiral tetrahydroindazole derivatives 95
Chromatographic separation of free dafachronic acid epimers with a novel triazole click quinidine-based chiral stationary phase 94
Dissecting the allosteric FXR modulation: A chemical biology approach using guggulsterone as a chemical tool 93
Atypical enantioseparation of a non-ionic form of allantoin with Cinchona alkaloid-based zwitterionic chiral stationary phases 92
Discovery and characterization of novel potent PARP-1 inhibitors endowed with neuroprotective properties: From TIQ-A to HYDAMTIQ 92
Investigating the allosteric reverse signalling of PARP inhibitors with microsecond molecular dynamic simulations and fluorescence anisotropy 91
4,5-Diarylisoxazol-3-carboxylic acids: A new class of leukotriene biosynthesis inhibitors potentially targeting 5-lipoxygenase-activating protein (FLAP) 91
Recent advances in urea- and thiourea-containing compounds: focus on innovative approaches in medicinal chemistry and organic synthesis 91
Discovery of 3α,7α,11β-Trihydroxy-6α-ethyl-5β-cholan-24-oic Acid (TC-100), a Novel Bile Acid as Potent and Highly Selective FXR Agonist for Enterohepatic Disorders 90
Targeting the conformational transitions of MDM2 and MDMX: insights into dissimilarities and similarities of p53 recognition. 89
Expanding the horizon of chemotherapeutic targets: From MDM2 to MDMX (MDM4). 88
Targeting the Conformational Transitions of MDM2 and MDMX. PART II: Insights into Key Residues Affecting p53 Recognition. 88
N-Aryl-5-aminopyrazole: A Versatile Architecture in Medicinal Chemistry 88
A Natural Prothrombin Mutant Reveals an Unexpected Influence of A-chain Structure on the Activity of Human {alpha}-Thrombin 87
Last ten years (2008–2018) of chiral ligand-exchange chromatography in HPLC: An updated review 87
Targeting the FXR Nuclear Receptor through a Virtual Screening Approach 86
Effects of Molecular Dynamics and Replica Exchange Molecular Dynamics in Sampling the Conformational Space of PARP-1 86
Microsampling and enantioselective liquid chromatography coupled to mass spectrometry for chiral bioanalysis of novel psychoactive substances 85
Synthesis and Characterization of Chiral Iridium Complexes Bearing Carbohydrate Functionalized Pyridincarboxamide Ligands and Their Application as Catalysts in the Asymmetric Transfer Hydrogenation of α-Ketoacids in Water 85
Quantum mechanics/molecular mechanics (QM/MM) modeling of the irreversible transamination of L-kynurenine to kynurenic acid: The round dance of kynurenine aminotransferase II 85
Profiling calcium-dependent interactions between Sorcin and intrinsically disordered regions of human proteome 85
Fluorinated Benzyloxyphenyl Piperidine-4-carboxamides with Dual Function against Thrombosis: Inhibitors of Factor Xa and Platelet Aggregation 84
Concepts and Molecular Aspects in the Polypharmacology of PARP-1 Inhibitors 84
Insights in the PARP1 poisoning effect 84
Reshaping antibiotics through hydrophobic drug-bile acid ionic complexation enhances activity against Staphylococcus aureus biofilms 84
Docking Studies and Molecular Dynamic Simulations Reveal Different Features of IDO1 Structure 84
Synthesis, physicochemical properties, and biological activity of bile acids 3-glucuronides: Novel insights into bile acid signalling and detoxification 84
Targeting the Conformational Transitions of MDM2 and MDMX. PART I: Insights into Dissimilarities and Similarities of p53 Recognition 83
Structural Basis of Human Dimeric α-Amino-β-Carboxymuconate-ε-Semialdehyde Decarboxylase Inhibition With TES-1025 83
Computational Modeling Overview and Evolution 82
Synthesis and monoamine oxidase inhibitory activity of new pyridazine-, pyrimidine- and 1,2,4-triazine-containing tricyclic derivatives 81
New potent and selective FXR agonists: design, synthesis and modeling of norcholanylamine derivatives 80
Design, synthesis, molecular modeling and biological activity of chenodeoxycholic acid carbamate derivatives as potent and selective FXR agonists 80
A rational approach to elucidate human monoamine oxidase molecular selectivity 80
Enantioseparation of novel anti-inflammatory chiral sulfoxides with two cellulose dichlorophenylcarbamate-based chiral stationary phases and polar-organic mobile phase(s) 80
Environmentally Sustainable Achiral and Chiral Chromatographic Analysis of Amino Acids in Food Supplements 78
A journey in unraveling the enantiorecognition mechanism of 3,5-dinitrobenzoyl-amino acids with two Cinchona alkaloid-based chiral stationary phases: The power of molecular dynamic simulations 77
Targeting the conformational transitions of MDM2 and MDMX: Insights into key residues affecting p53 recognition 77
Synthesis and biological activity of cyclopropyl Δ7-dafachronic acids as DAF-12 receptor ligands 76
Efficient enantioresolution of aromatic α-hydroxy acids with Cinchona alkaloid-based zwitterionic stationary phases and volatile polar-ionic eluents 74
Elucidation of retention mechanism of dipeptides on a ristocetin A-based chiral stationary phase using a combination of chromatographic and molecular simulation techniques 74
Chemical exploration of TGR5 functional hot-spots: Synthesis and structure-activity relationships of C7- and C23-Substituted cholic acid derivatives 73
Molecular Dynamics-Ensemble Docking and Biophysical Studies for Structure-Based Identification of Non-Amino Acidic Ligands of DDAH-1 73
Extending SAR of bile acids as FXR ligands: Discovery of 23-N-(carbocinnamyloxy)-3a,7a-dihydroxy-6a-ethyl-24-nor-5b-cholan-23-amine 73
Investigation on the Antiplatelet Activity of Pyrrolo[3,2-c]pyridine-Containing Compounds 72
HYDAMTIQ: A New, Potent PARP-1 Inhibitor with Neuroprotective Properties 72
Synthesis and biological evaluation of direct thrombin inhibitors bearing 4-(piperidin-1-yl)pyridine at the P1 position with potent anticoagulant activity. 72
Therapeutic Potential of a Novel Poly(ADP-ribose) Polymerase Inhibitor, Hydamtiq, in Human Pancreatic and Colon Cancers 72
Discovery of Novel 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors by Exploiting a Multistep Virtual Screening Protocol 72
Multiple Heart-Cutting Two-Dimensional HPLC-UV Achiral–Chiral Analysis of Branched-Chain Amino Acids in Food Supplements under Environmentally Friendly Conditions 71
Pyrazole[3,4-e][1,4]thiazepin-7-one derivatives as a novel class of Farnesoid X Receptor (FXR) agonists 71
Design, Synthesis, Crystallographic Studies and Preliminary Biological Appraisal of New Substituted Triazolo[4,3-b]pyridazin-8-amine Derivatives as Tankyrase Inhibitors. 70
The "racemic approach" in the evaluation of the enantiomeric NorA efflux pump inhibition activity of 2-phenylquinoline derivatives 70
ENVIRONMENTALLY FRIENDLY, SEQUENTIAL, ONE-POT SYNTHESIS OF N-ARYL-5-AMINOPYRAZOLES FROM ANILINES 70
Exploring the effect of PARP-1 flexibility in docking studies 68
Enantioseparations by high-performance liquid chromatography based on chiral ligand exchange 68
Chiral high-performance liquid chromatography analysis of mono-, di-, and triacylglycerols with amylose- and cellulose-phenylcarbamate-based stationary phases 67
Deconstructing bile acid signaling pathways 67
Diastereo- and enantioseparation of a Nα-Boc amino acid with a zwitterionic quinine-based stationary phase: Focus on the stereorecognition mechanism 67
STUDY OF THE MICELLE FORMATION PROCESS OF BILE ACIDS THROUGHMOLECULAR DYAMICS SIMULATIONS 66
Ester derivatives of annulated tetrahydroazocines: a new class of selective acetylcholinesterase inhibitors 66
Totale 9.208
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.433
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.433
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021109 0 0 0 0 0 0 0 0 0 15 34 60
2021/2022823 15 132 6 21 15 16 22 285 26 57 96 132
2022/20231.714 126 311 26 124 123 187 7 88 624 17 67 14
2023/2024803 55 106 40 12 11 15 156 29 82 33 120 144
2024/20252.080 39 193 122 79 246 144 146 96 413 133 320 149
2025/20264.212 298 343 236 536 617 400 791 253 435 303 0 0
Totale 11.303